GW0742 | 120 x 5 mg

SAFETY DATA SHEET

GW0742, also known as GW610742, is a potent and highly selective PPARδ (peroxisome proliferator-activated receptor delta) agonist. As a close structural analog of GW-501516 (Cardarine), GW0742 is designed to exhibit even greater selectivity and affinity for the PPARδ receptor, with minimal off-target interaction.

By activating PPARδ, GW0742 modulates gene expression involved in lipid metabolism, glucose homeostasis, mitochondrial biogenesis, and inflammation, making it a powerful tool for studying metabolic disorders, obesity, atherosclerosis, and endurance enhancement in preclinical models.

Research has shown that GW0742 may:

• Enhance mitochondrial β-oxidation and overall energy expenditure, particularly within skeletal muscle tissue, as observed in rodent models
• Improve insulin sensitivity and glucose homeostasis, contributing to favorable metabolic outcomes in experimental models of insulin resistance and Type 2 diabetes
• Attenuate adipose tissue accumulation, even under high-fat dietary conditions, indicating potential utility in models of diet-induced obesity
• Downregulate pro-inflammatory cytokine expression, supporting its investigation in inflammation-related disease models
• Modulate endothelial function and vascular tone, with implications for preclinical research in cardiovascular and metabolic vascular dysfunction

GW0742 is not an androgen receptor modulator or SARM, but is often studied alongside such compounds due to its effects on body composition, endurance, and metabolic efficiency.

⚠ Important Note: This product is supplied strictly for laboratory research use only. It is not approved for human consumption or therapeutic use. Not intended to diagnose, treat, cure, or prevent any disease.